Charts RespireRx Pharmaceuticals Inc.

Equities

Market Closed - OTC Markets Other stock markets 14:26:13 2024-05-14 EDT			5-day change	1st Jan Change
0.00096 ^USD	+1.05%		+11.11%	+11.11%

04-10	RespireRx Pharmaceuticals Inc. announced that it has received $0.1 million in funding	CI
03-20	RespireRx Pharmaceuticals Inc. Reports Publication of Preclinical Research Results Demonstrating the Ability of CX1739, its Lead Clinical AMPAkine, to Improve Bladder Function After Spinal Cord Injury	CI

ProRealTime Chart